Last update 01 Nov 2024
Youhua Pharmaceutical (Leshan) Co Ltd

Youhua Pharmaceutical (Leshan) Co Ltd

Private Company|
2004|
Sichuan Sheng, China
|
www.yhpls.com

Overview

Tags

Infectious Diseases
Nervous System Diseases
Congenital Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases4
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug5
Top 5 TargetCount
bacterial DHPS(Bacterial dihydropteroate synthase)1
GABAA receptor(Gamma-aminobutyric acid A receptor)1
Tubulin1
Bacterial DHFR(Bacterial dihydrofolate reductase)1

Related

5
Drugs associated with Youhua Pharmaceutical (Leshan) Co Ltd
Sodium Houttuyfonate
Target-
Mechanism-
Active Org.
Youhua Pharmaceutical (Leshan) Co LtdYouhua Pharmaceutical (Leshan) Co Ltd
Originator Org.
Youhua Pharmaceutical (Leshan) Co LtdYouhua Pharmaceutical (Leshan) Co Ltd
Active Indication
Bronchitis, Chronic
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1981
Trimethoprim
Target
Bacterial DHFR
Mechanism
Bacterial DHFR inhibitors
Active Org.
Dr. Reddy's Laboratories SA [+2]
Originator Org.
Monarch Pharmaceuticals LLC
Active Indication
Urinary Tract Infections [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date30 May 1980
Phenobarbital Sodium
Target
GABAA receptor
Mechanism
GABAA receptor agonists
Active Org.
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. [+8]
Originator Org.
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc.
Active Indication
Epilepsy, Benign Neonatal [+6]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date04 Mar 1980
1
Clinical Trials associated with Youhua Pharmaceutical (Leshan) Co Ltd
CTR20213455 / CompletedNot Applicable
孟鲁司特钠颗粒在中国健康受试者中进行的单中心、随机、开放、单次（空腹/餐后）口服给药、两制剂、两序列、两周期、交叉的人体生物等效性试验
[Translation] A single-center, randomized, open-label, single-dose (fasting/postprandial) oral bioequivalence study of montelukast sodium granules in healthy Chinese subjects: two-formulation, two-sequence, two-period, crossover
100 Clinical Results associated with Youhua Pharmaceutical (Leshan) Co Ltd
Login to view more data
0 Patents (Medical) associated with Youhua Pharmaceutical (Leshan) Co Ltd
Login to view more data
100 Deals associated with Youhua Pharmaceutical (Leshan) Co Ltd
Login to view more data
100 Translational Medicine associated with Youhua Pharmaceutical (Leshan) Co Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
5
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free